PER percheron therapeutics limited

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-68

  1. 1,031 Posts.
    lightbulb Created with Sketch. 431
    Meanwhile JG and directors still lining their pockets

    They should all stand down and let someone take the shell and cash

    Shout out to Mark Diamond as well, longest ever serving ASX biotech CEO, for 20 years of kicking the can down the road and getting away with it
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $9.786M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $94.66K 10.09M

Buyers (Bids)

No. Vol. Price($)
4 661860 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1588275 6
View Market Depth
Last trade - 15.52pm 27/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.